Acutaas Chemical

Which are the latest news on Acutaas Chemical?

Why is Acutaas Chemicals Ltd falling/rising?

As of 05-Sep, Acutaas Chemicals Ltd's stock price is falling by 1.04%, despite strong long-term performance with an 85.91% year-to-date return. The decline may indicate market corrections or profit-taking, although positive signs include rising investor participation and a low debt-to-equity ratio.

As of 05-Sep, Acutaas Chemicals Ltd's stock price is currently falling, as indicated by a change of -33.15, which represents a decline of 1.04%. This drop in price occurs despite the company's strong long-term performance, including an impressive year-to-date return of 85.91% and a one-year return of 122.14%, significantly outperforming the broader market, which has seen a decline of 10.21% over the same period.<BR><BR>Today's performance shows that the stock has underperformed its sector by 1.36%. Additionally, while the stock is trading above its 100-day and 200-day moving averages, it is below its 5-day, 20-day, and 50-day moving averages, suggesting a short-term weakness in momentum. <BR><BR>Despite these challenges, there are positive indicators such as rising investor participation, with a delivery volume increase of 15.81% compared to the 5-day average, and a healthy financial profile characterized by a low debt-to-equity ratio of 0.05 times and consistent growth in net sales and operating profit. However, the current price decline may reflect market corrections or profit-taking by investors after a substantial rise in stock value over the past year.

Who are in the management team of Acutaas Chemical?

The management team of Acutaas Chemical includes Chairman Nareshbhai Ramjibhai Patel, Whole-time Directors Chetankumar Chhaganlal Vaghasia, Virendra Nath Mishra, and Ram Mohan Rao Locande, along with Independent Non-Executive Directors Girikrishna Maniar, Hetal Gandhi, Richa M. Goyal, and Anita Bandyopadhyay. They are responsible for guiding the company's strategic direction and operations.

The management team of Acutaas Chemical includes the following key members:<BR><BR>1. **Nareshbhai Ramjibhai Patel** - Chairman / Executive Director<BR>2. **Chetankumar Chhaganlal Vaghasia** - Whole-time Director<BR>3. **Virendra Nath Mishra** - Whole-time Director<BR>4. **Ram Mohan Rao Locande** - Whole-time Director<BR>5. **Girikrishna Maniar** - Independent Non-Executive Director<BR>6. **Hetal Gandhi** - Independent Non-Executive Director<BR>7. **Richa M. Goyal** - Independent Non-Executive Director<BR>8. **Anita Bandyopadhyay** - Independent Non-Executive Director<BR><BR>This team plays a crucial role in guiding the company's strategic direction and operations.

What does Acutaas Chemical do?

Acutaas Chemicals Ltd is a small-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of 330 Cr and a net profit of 74 Cr for June 2026. It was founded in 2004 as "Ami Organics" and later became a private limited company.

Overview: <BR>Acutaas Chemicals Ltd operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Small Cap company.<BR><BR>History: <BR>Acutaas Chemicals Ltd was initially formed as a partnership firm named "Ami Organics" on 03 January 2004 in Surat, India. It transitioned to a Private Limited Company under the name "Ami Organics Private Limited" with a Certificate of Incorporation dated 12 June 2007. The latest quarterly results report net sales and profit for June 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 330 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 74 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 26,550 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 67.00 <BR>Industry P/E: 43 <BR>Dividend Yield: 0.05% <BR>Debt Equity: -0.11 <BR>Return on Equity: 21.54% <BR>Price to Book: 16.14<BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Who are the peers of the Acutaas Chemical?

Acutaas Chemical's peers include Sai Life, Wockhardt, Neuland Labs, Piramal Pharma, Pfizer, Granules India, Caplin Point Lab, ERIS Lifescience, and Astrazeneca Pharma. Acutaas Chemical excels in management risk, growth, and capital structure, achieving the highest 1-year return at 124.38%, while ERIS Lifescience has the lowest return at -27.88%.

Peers: The peers of Acutaas Chemical are Sai Life, Wockhardt, Neuland Labs., Piramal Pharma, Pfizer, Granules India, Caplin Point Lab, ERIS Lifescience, and Astrazeneca Phar.<BR><BR>Quality Snapshot: Excellent management risk is observed at Neuland Labs. and Astrazeneca Phar, while Good management risk is found at Acutaas Chemical, Pfizer, Granules India, Caplin Point Lab, and ERIS Lifescience, and Average management risk is present at Sai Life, Wockhardt, and Piramal Pharma. In terms of Growth, Excellent growth is noted at Acutaas Chemical and Neuland Labs., while Good growth is seen at Wockhardt, and Below Average growth is observed at Piramal Pharma, Pfizer, Granules India, Caplin Point Lab, ERIS Lifescience, and Astrazeneca Phar. For Capital Structure, Excellent capital structure is attributed to Acutaas Chemical, Neuland Labs., Pfizer, Granules India, Caplin Point Lab, and Astrazeneca Phar, while Average capital structure is noted at ERIS Lifescience, and Below Average capital structure is found at Wockhardt and Piramal Pharma.<BR><BR>Return Snapshot: Acutaas Chemical has the highest 1-year return at 124.38%, while ERIS Lifescience has the lowest at -27.88%. Acutaas Chemical's return significantly outperforms all peers. Additionally, ERIS Lifescience is the only peer with a negative six-month return.

How big is Acutaas Chemical?

As of 31st August, Acutaas Chemicals Ltd has a market capitalization of 26,550.00 Cr, with recent net sales of 1,461.80 Cr and a net profit of 386.22 Cr. Shareholder's funds are reported at 1,309.63 Cr, and total assets at 1,549.26 Cr as of March 2025.

As of 31st August, Acutaas Chemicals Ltd has a market capitalization of 26,550.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, Acutaas Chemicals reported Net Sales of 1,461.80 Cr and a Net Profit of 386.22 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds reported at 1,309.63 Cr and Total Assets at 1,549.26 Cr.

Should I buy, sell or hold Acutaas Chemicals Ltd?

Are Acutaas Chemicals Ltd latest results good or bad?

Acutaas Chemicals Ltd's latest results show strong year-on-year growth in net sales (up 59.08%) and net profit (up 67.67%), but there are concerning quarter-on-quarter declines in both metrics (net profit down 43.64% and net sales down 23.82%), indicating potential operational challenges. Investors should monitor how management addresses these issues moving forward.

Acutaas Chemicals Ltd's latest results present a mixed picture. On one hand, the company reported a significant year-on-year increase in net sales and net profit, with net sales rising by 59.08% compared to the same quarter last year, and net profit increasing by 67.67% year-on-year. This indicates strong revenue growth and an ability to capture market share.<BR><BR>However, the quarter-on-quarter performance reveals concerning trends. Net profit fell by 43.64% and net sales decreased by 23.82% compared to the previous quarter. Additionally, there was a notable decline in operating margin, which dropped by 808 basis points to 34.29%. This margin compression raises questions about the company's pricing power and operational efficiency, especially given the rising input costs and potential operational challenges.<BR><BR>Overall, while Acutaas Chemicals shows strong year-on-year growth, the significant sequential declines in profitability and sales suggest that the company is facing operational headwinds that could impact its premium valuation. Investors may need to closely monitor how management addresses these challenges in the upcoming quarters.

When is the next results date for Acutaas Chemicals Ltd?

The next results date for Acutaas Chemicals Ltd is 28 January 2026.

The next results date for Acutaas Chemicals Ltd is scheduled for 28 January 2026.

How has been the historical performance of Acutaas Chemical?

Acutaas Chemical has shown significant growth over the past five years, with net sales increasing from 340.61 Cr in March 2021 to 1,006.88 Cr in March 2025, and profit after tax rising from 54.00 Cr to 160.42 Cr in the same period. The company's total assets also expanded from 231.89 Cr to 1,549.26 Cr, reflecting strong operational efficiency and profitability.

Answer:<BR>The historical performance of Acutaas Chemical shows significant growth in net sales and profitability over the past five years, culminating in the fiscal year ending March 2025.<BR><BR>Breakdown:<BR>Acutaas Chemical's net sales have increased from 340.61 Cr in March 2021 to 1,006.88 Cr in March 2025, reflecting a strong upward trend. The total operating income has similarly risen, reaching 1,006.88 Cr in March 2025, up from 340.61 Cr in March 2021. The company's operating profit (PBDIT) has also shown substantial growth, climbing from 81.54 Cr in March 2021 to 249.01 Cr in March 2025, indicating improved operational efficiency. Profit before tax surged to 216.16 Cr in March 2025 from 71.73 Cr in March 2021, while profit after tax reached 160.42 Cr, up from 54.00 Cr in March 2021. The consolidated net profit for March 2025 stood at 158.71 Cr, a significant increase from 42.77 Cr in March 2024. Furthermore, total assets have expanded from 231.89 Cr in March 2020 to 1,549.26 Cr in March 2025, with total liabilities increasing from 231.89 Cr to 1,549.26 Cr in the same period. The cash flow from operating activities has remained positive, amounting to 118.00 Cr in March 2025, although cash flow from investing activities has been negative at -223.00 Cr. Overall, Acutaas Chemical has demonstrated robust growth in revenue and profitability, alongside a significant increase in total assets and liabilities.

Is Acutaas Chemical technically bullish or bearish?

As of October 1, 2025, the technical trend has shifted to bullish with strong indicators like the weekly MACD and Bollinger Bands supporting upward momentum, although caution is advised due to a mildly bearish monthly MACD and Dow Theory on the weekly timeframe.

As of 1 October 2025, the technical trend has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands are bullish, indicating upward momentum. Daily moving averages are also bullish, reinforcing the positive trend. However, the monthly MACD is mildly bearish and the Dow Theory shows a mildly bearish stance on the weekly timeframe, which suggests some caution. Overall, the strength of the bullish trend is supported by the KST being bullish on both weekly and monthly timeframes.

Who are the top shareholders of the Acutaas Chemical?

The top shareholders of Acutaas Chemical include promoters, with Nareshkumar Ramjibhai Patel holding 19.34%, institutional investors with 19 mutual funds owning 13.02% and 110 foreign institutional investors holding 16.48%, and individual investors collectively owning 24.19%. The SBI Large & Midcap Fund is the largest public shareholder at 4.23%.

The top shareholders of Acutaas Chemical include a mix of promoters, institutional investors, and individual shareholders. The majority of the shares are held by promoters, with Nareshkumar Ramjibhai Patel being the promoter with the highest holding at 19.34%. <BR><BR>In terms of institutional investment, 19 mutual funds collectively hold 13.02% of the shares, while 110 foreign institutional investors (FIIs) hold 16.48%. The highest public shareholder is the SBI Large & Midcap Fund, which holds 4.23%. Additionally, individual investors collectively own 24.19% of the company.

Is Acutaas Chemical overvalued or undervalued?

As of September 17, 2021, Acutaas Chemical is considered very expensive and overvalued with a PE ratio of 58.75, significantly higher than its peers, despite strong returns of 84.28% over the past year, which outperformed the Sensex's 7.55% return.

As of 17 September 2021, Acutaas Chemical's valuation grade has moved from does not qualify to very expensive, indicating a significant shift in its market perception. The company is currently assessed as overvalued. Key financial ratios include a PE ratio of 58.75, an EV to EBITDA ratio of 39.16, and a PEG ratio of 0.64, which suggest that despite a high growth potential, the current price does not justify the earnings.<BR><BR>In comparison to its peers, Acutaas Chemical's PE ratio is notably higher than Godrej Industries Ltd., which has a PE of 46.63, and Deepak Nitrite Ltd., with a PE of 37.97. This reinforces the notion that Acutaas is trading at a premium relative to companies within the same sector. Additionally, while Acutaas has shown strong returns over the past year at 84.28%, it has underperformed against the Sensex's return of 7.55% during the same period, further highlighting its overvaluation in the current market context.

Has Acutaas Chemical declared dividend?

Acutaas Chemicals Ltd has declared a 30% dividend, amounting to 3 per share, with an ex-date of September 18, 2023. Despite this, the dividend yield is 0%, as the company has not provided significant dividend returns in recent years, although it has shown strong price performance.

Acutaas Chemicals Ltd has declared a 30% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 30%<BR>- Amount per share: 3 per share<BR>- Ex-date: 18 Sep 23<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the last 6 months, Acutaas Chemicals Ltd achieved a price return of 3.82%, with no dividend return, resulting in a total return of 3.82%.<BR><BR>Over the past year, the company saw a price return of 89.48%, with no dividend return, leading to a total return of 89.48%.<BR><BR>In the 2-year period, the price return was 91.7%, with a dividend return of 0.46%, culminating in a total return of 92.16%.<BR><BR>For the 3-year period, the price return reached 146.75%, with a dividend return of 1.41%, resulting in a total return of 148.16%.<BR><BR>In the last 4 years, there was no price or dividend return, resulting in a total return of 0.0%.<BR><BR>Over the 5-year period, the company also recorded no price or dividend return, leading to a total return of 0.0%.<BR><BR>Overall, Acutaas Chemicals Ltd has declared a dividend, but the dividend yield remains at 0%. The total returns over various periods indicate strong price performance, particularly in the 1 and 3-year periods, despite the lack of significant dividend contributions.